EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beneficial Handling of Molecular Chaperones (Chaperonotherapy) in Glioblastoma and Neuroblastoma: Novel Therapeutic Targets or Potential Agents?

Maria Antonella Augello iD, Nima Shadan iD, Giuseppa D'Amico iD, Rosario Barone iD, Celeste Caruso Bavisotto iD, Federica Scalia, Alessandra Maria Vitale iD

Cells · 2025

DOI: 10.3390/cells14181447 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Maria Antonella Augello und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Molecular Chaperones, Neuroblastoma, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Molecular chaperones, especially Heat Shock Proteins (HSPs), play complex, context-dependent roles in cancer, particularly in nervous system (NS) tumors like glioblastoma (GBM) and neuroblastoma (NB). They are often upregulated, promoting tumor growth, poor prognosis, and resistance to therapy and immune responses. This supports the potential of negative chaperonotherapy, aimed at inhibiting them. However, some studies suggest chaperones can also act as tumor suppressors in certain cancers, indicating that positive chaperonotherapy—enhancing or restoring their function—may be beneficial. For NS tumors, this latter area is still understudied. With emphasis on GBM and NB, in this review we address the potential of molecular chaperones, particularly HSPs, as therapeutic targets or agents. We discuss strategies to inhibit pro-tumorigenic chaperones as well as the underexplored potential of chaperone induction and immunomodulation. Ultimately, we examine the emerging use of pharmacological and chemical chaperones to improve treatment outcomes in these NS tumors. These strategies, whether applied alone or in combination, may offer significant benefits for GBM and NB, which are presently among the most aggressive and challenging tumors to manage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMolecular ChaperonesNeuroblastomaBrain NeoplasmsHumansAnimalsMolecular Targeted TherapyHeat-Shock Proteins

Stichwörter der Autor:innen

Chaperone SystemHeat Shock Proteinschaperonopathieschaperonotherapiesglioblastomaimmune systemimmunotherapymolecular chaperonesnervous system tumorsneuroblastoma

Substanzen

Molecular ChaperonesHeat-Shock Proteins

Autor:innen und Institutionen

  • Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, 90127 Palermo, Italy.
  • Department of Medicine and Surgery, Kore University of Enna, 94100 Enna, Italy.

ORCID-Profile: Maria Antonella Augello, Nima Shadan, Giuseppa D'Amico, Rosario Barone, Celeste Caruso Bavisotto, Alessandra Maria Vitale

Zitieren

APA

Augello, M. A., Shadan, N., D'Amico, G., Barone, R., Caruso Bavisotto, C., Scalia, F., & Vitale, A. M. (2025). Beneficial Handling of Molecular Chaperones (Chaperonotherapy) in Glioblastoma and Neuroblastoma: Novel Therapeutic Targets or Potential Agents?. Cells. https://doi.org/10.3390/cells14181447

Vancouver

Augello MA, Shadan N, D'Amico G, Barone R, Caruso Bavisotto C, Scalia F, et al. Beneficial Handling of Molecular Chaperones (Chaperonotherapy) in Glioblastoma and Neuroblastoma: Novel Therapeutic Targets or Potential Agents?. Cells. 2025. doi:10.3390/cells14181447

BibTeX
@article{Augello2025,
  author = {Augello, Maria Antonella and Shadan, Nima and D'Amico, Giuseppa and Barone, Rosario and Caruso Bavisotto, Celeste and Scalia, Federica and Vitale, Alessandra Maria},
  title = {Beneficial Handling of Molecular Chaperones (Chaperonotherapy) in Glioblastoma and Neuroblastoma: Novel Therapeutic Targets or Potential Agents?},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14181447}
}
Kostenlos starten →